Table 1. Scoring systems used to analyse associations of coagulation abnormalities and mortality
From: COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
A. ISTH SIC scoring system | ||
|---|---|---|
Item | Score | Range |
Platelet count (×109/L) | 1 | 100-150 |
2 | <100 | |
PT-INR | 1 | 1.2-1.4 |
2 | >1.4 | |
SOFA score | 1 | 1 |
2 | ≥2 |
B. Chinese DIC scoring system | |
|---|---|
Item | Score |
Primary disease leading to DIC | 2 |
Clinical manifestations | |
Severe bleeding | 1 |
Shock | 1 |
Extensive cutaneous and mucosal embolism, or focal ischemic necrosis, or unexplained organ failure | 1 |
Platelet count (×109/L) | |
Non-hematology malignancy | |
≥100 | 0 |
80–< 100 | 1 |
<80 | 2 |
Decrease > 50% within 24h | 1 |
Hematology malignancy | |
< 50 | 1 |
Decrease > 50% within 24h | 1 |
D-dimer (mg/L) | |
< 5 | 0 |
5–< 9 | 2 |
≥9 | 3 |
PT and aPTT (sec) | |
Prolongation of PT< 3 or aPTT< 10 | 0 |
Prolongation of PT≥3 or aPTT≥10 | 1 |
Prolongation of PT≥6 | 2 |
Fbg (g/L) | |
≥1.0 | 0 |
< 1.0 | 1 |